User profiles for Ralph Vassallo

Ralph Vassallo

Vitalant
Verified email at vitalant.org
Cited by 2468

Estimated US infection-and vaccine-induced SARS-CoV-2 seroprevalence based on blood donations, July 2020-May 2021

…, BJ Biggerstaff, D Strauss, D Kessler, R Vassallo… - Jama, 2021 - jamanetwork.com
Importance People who have been infected with or vaccinated against SARS-CoV-2 have
reduced risk of subsequent infection, but the proportion of people in the US with SARS-CoV-2 …

[HTML][HTML] Structure-function relationships in the activation of platelet thrombin receptors by receptor-derived peptides.

RR Vassallo Jr, T Kieber-Emmons, K Cichowski… - Journal of Biological …, 1992 - Elsevier
According to present models, thrombin activates platelets by cleaving its receptors after
Arg41, creating a new N terminus which acts as a tethered ligand. In support of this model, a …

Clinical practice guidelines from the Association for the Advancement of Blood and Biotherapies (AABB): COVID-19 convalescent plasma

…, JS Raval, TW Rice, BH Shaz, RR Vassallo… - Annals of internal …, 2022 - acpjournals.org
Description: Coronavirus disease 2019 convalescent plasma (CCP) has emerged as a potential
treatment of COVID-19. However, meta-analysis data and recommendations are limited. …

[HTML][HTML] It's time to phase-in RHD genotyping for patients with a serological weak D phenotype

…, ST Johnson, L Katz, JT Queenan, RR Vassallo… - Transfusion, 2015 - ncbi.nlm.nih.gov
In 2014, the College of American Pathologists (CAP) Transfusion Medicine Resource
Committee (TMRC) reported the results of a survey of more than 3100 laboratories concerning …

A critical comparison of platelet preparation methods

RR Vassallo, S Murphy - Current opinion in hematology, 2006 - journals.lww.com
We present a literature-based review of the relative merits of apheresis-derived and whole-blood-derived
platelets. Additional studies are needed in order to define the optimal …

Access to and safety of COVID-19 convalescent plasma in the United States Expanded Access Program: A national registry study

…, LJ Dumont, SE Baker, RR Vassallo… - PLoS …, 2021 - journals.plos.org
Background The United States (US) Expanded Access Program (EAP) to coronavirus disease
2019 (COVID-19) convalescent plasma was initiated in response to the rapid spread of …

How do we manage iron deficiency after blood donation?

JE Kiss, RR Vassallo - British journal of haematology, 2018 - Wiley Online Library
Blood donors and the RBCs and other components they willingly provide are essential in
the delivery of healthcare in all parts of the world. Nearly 70% of donated blood comes from …

Guidance on platelet transfusion for patients with hypoproliferative thrombocytopenia

…, S Tanael, P Rebulla, K Pavenski, R Vassallo… - Transfusion medicine …, 2015 - Elsevier
… ; Ralph Vassallo: no financial disclosures; intellectual disclosure, research funding from
Fenwal, Inc; Paolo Rebulla: scientific advisory board of Macopharma, research funding from …

SARS‐CoV‐2 antibody persistence in COVID‐19 convalescent plasma donors: dependency on assay format and applicability to serosurveillance

…, JE Gomez, J Livny, DT Hung, R Vassallo… - …, 2021 - Wiley Online Library
Background Antibody response duration following severe acute respiratory syndrome
coronavirus 2 infection tends to be variable and depends on severity of disease and method of …

[HTML][HTML] COVID‐19 convalescent plasma: interim recommendations from the AABB

…, JS Raval, TW Rice, BH Shaz, RR Vassallo… - Transfusion, 2021 - ncbi.nlm.nih.gov
2. METHODS The AABB Board of Directors commissioned a committee of experts to draft
clinical practice guidelines for the use of CCP. The primary focus was to evaluate whether CCP …